Case Investigations

Acorda Therapeutics, Inc.

November 15, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).

Genocea Biosciences, Inc.

November 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Genocea Biosciences, Inc. (“Genocea” or the “Company”) (NASDAQ: GNCA).  Genocea is a biopharmaceutical company developing vaccines and immunotherapies.

Trivago N.V.

November 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trivago N.V. (“Trivago” or the “Company”) (NASDAQ: TRVG).

The Advisory Board Company

September 6, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating The Advisory Board Company ("Advisory Board” or the "Company") (NASDAQ: ABCO), a company that provides performance-improvement software and services to the healthcare and education industries.  Investors who purchased shares of Advisory Board common stock may be affected.

SteadyMed Ltd.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. (“SteadyMed” or the “Company”) (NASDAQ: STDY).

DryShips Inc.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DryShips Inc. (“DryShips” or the “Company”) (NASDAQ: DRYS).